Subchronic exposure to pharmacological levels of estrogenic compounds, including 1713-estradiol, diethylstilbestrol, and a-dienestrol, significantly increased the mortality of B6C3F, female mice after Listeria infection. Compounds with little estrogenic activity, including 5a-dihydrotestosterone, progesterone, zearalenol, and corticosterone, did not alter Listeria-related mortality. Estrogen-induced alterations in resistance were inhibited by both adult thymectomy and the estrogen antagonist tamoxifen. Pharmacological (i.e., therapeutic) levels of estrogen alter resistance to a variety of infections in laboratory animals. For example, estrogen-treated mice are less susceptible than controls to bacteria such as Pneumococcus type I, Pasteurella spp., and Salmonella spp. (30). Mice exposed to diethylstilbestrol (DES) are more resistant to the formation of transplantable lung melanoma tumors (8, 29) , and estrogens may also lessen the severity of certain plasmodial, babesial, and trypanosomal infections (2, 17, 26) . Paradoxically, exposure to pharmacological levels of estrogen profoundly decreases host resistance to a variety of other infectious agents. Illustrative of this are the findings that DES exposure precipitates a dramatic increase in Listeria susceptibility, impairs the intestinal expulsion of adult Trichinella sp., and increases the susceptibility of mice to both viral and methylcholanthrene-induced tumors (4, 15). 1713-Estradiol induces more intense chlamydial (36) and staphylococcal (47) infections, whereas hexestrol administration increases the severity of experimental toxoplasmosis in mice (18).
Pharmacological (i.e., therapeutic) levels of estrogen alter resistance to a variety of infections in laboratory animals. For example, estrogen-treated mice are less susceptible than controls to bacteria such as Pneumococcus type I, Pasteurella spp., and Salmonella spp. (30) . Mice exposed to diethylstilbestrol (DES) are more resistant to the formation of transplantable lung melanoma tumors (8, 29) , and estrogens may also lessen the severity of certain plasmodial, babesial, and trypanosomal infections (2, 17, 26) . Paradoxically, exposure to pharmacological levels of estrogen profoundly decreases host resistance to a variety of other infectious agents. Illustrative of this are the findings that DES exposure precipitates a dramatic increase in Listeria susceptibility, impairs the intestinal expulsion of adult Trichinella sp., and increases the susceptibility of mice to both viral and methylcholanthrene-induced tumors (4, 15) . 1713-Estradiol induces more intense chlamydial (36) and staphylococcal (47) infections, whereas hexestrol administration increases the severity of experimental toxoplasmosis in mice (18) .
The divergent effects of estrogens on resistance may, in some instances, be due to the quantity of chemical injected (8) or the route of infection (29) . In addition, it is likely that altered host resistance correlates with immune function disturbances caused by estrogenic compounds. For example, estrogens are potent stimulants of the mononuclear phagocyte system (1, 22, 31, 49) but suppress natural killer cell activity (14, 41) and T cell-mediated immunity as well (12, 13, 23) . Estrogens may induce these alterations by affecting the production of immunoregulatory thymic hormones (9, 24, 42) . Increased resistance to certain organisms is often attributed to estrogen-related enhancement of mac-rophage activity (2, 17, 29, 30) . Conversely, estrogen-induced defects in natural killer cell functions and T-cell responses may decrease resistance to other infectious agents (4, 15, 18) .
The aim of the present study was to systematically examine the mechanisms associated with the increased susceptibility to Listeria monocytogenes infection which occurs after exposure to pharmacological levels of estrogen. The relationship between altered host resistance and the estrogenicity (i.e., uterotrophic activity) of sex hormones was determined by investigating the effect of a variety of steroidal and nonsteroidal compounds, with a range of estrogenic activities, on host resistance to L. monocytogenes. The role of the thymus and the operational estrogen receptor was studied by investigating the effects of adult thymectomy (TX) and the estrogen antagonist tamoxifen on Listeria resistance after estrogen exposure. In addition, studies were designed to determine the nature of the immune disturbances induced by estrogens which are responsible for the alterations in host resistance.
MATERIALS Statistical analysis. The chi-square test was used to assess the significance of treatment effects in mortality studies. Student's t test was used to compare results obtained from experimental groups in all other instances. RESULTS The administration of either estradiol or DES resulted in a marked increase in the susceptibility of female B6C3F1 mice to L. monocytogenes. Significantly increased mortality after Listeria infection occurred in mice treated with greater than 0.04 ,umol of DES or estradiol (Fig. 1 (Table 3) . Listeria-related mortality in mice dosed with tamoxifen plus estradiol was similar to that of vehicle controls. Exposure to tamoxifen alone did not affect survival.
Since it has been proposed that estrogens influence immune functions by altering thymic hormone levels (9, 24, 42), we examined the effect of surgical thymectomy (TX) on estrogen-induced alterations in host resistance. In these studies, adult female mice were thymectomized and treated with estradiol before L. monocytogenes infection. TX afforded protection against estrogen-altered host resistance after low-dose estrogen administration (Table 4) . Listeriarelated mortality in thymectomized mice dosed with 0.04 ,umol of estradiol was similar to that observed in vehicle controls. On the other hand, estradiol-exposed sham-operated mice had significantly higher mortality than did controls. The protective effect of TX on Listeria resistance was not observed in mice treated with a greater dose of estradiol (0.74 ,umol), which suggests that at higher exposure levels, nonthymic mechanisms may be involved. Intermediate dosage levels were not examined. A similar experiment was performed with transplantable tumor cell inoculation rather than Listeria infection to reconfirm that the thymus plays a role in estrogen-induced alterations of host resistance (Table  4) . TX protected mice against the effects of estrogen on syngeneic tumor formation. Tumor incidence in both DESexposed and control thymectomized mice was 50%. Tumor incidence in sham-operated mice treated with DES (90%) was significantly higher than in controls. The growth kinetics of L. monocytogenes in the spleens of estrogen-treated mice was determined by monitoring splenic bacterial growth over a 7-day period after i.v. inoculation with a sublethal dose of L. monocytogenes (Fig. 2) . One day after infection no differences were observed between the numbers of Listeria cells in the spleens of control and estrogen-treated mice. However, there were significantly higher numbers of bacteria in the spleens of both DES and estradiol-treated mice when compared with control mice on days 4 and 7 after infection. Estrogen exposure had the same effect on Listeria titers in the livers of i.v.-infected mice and the spleens of i.p.-infected mice (data not shown).
To examine the effect of estrogen exposure on leukocyte accumulation at infective foci, we determined the number of peritoneal lymphocytes, monocytes, and polymorphonuclear leukocytes (PMNs) after an i.p. injection of viable Listeria cells. At the same time the peritoneal growth kinetics of the bacteria were monitored. Estrogen exposure depressed the accumulation of lymphocytes and monocytes in the peritoneal cavities of i.p.-infected mice (Fig. 3) . The number of peritoneal lymphocytes and monocytes was greater in mice exposed to DES than in vehicle controls on the day of infection. However, the quantity of lymphocytes rose to significantly higher levels in the controls by day 4 after infection and remained elevated above peritoneal lymphocyte numbers in the DES-treated mice through day 5. The number of peritoneal monocytes increased to significantly higher levels in the controls than in the DES-treated mice on days 3 and 4 after infection. Comparable quantities of monocytes were not observed in the DES-exposed animals until day 5. DES treatment augmented rather than delayed the accumulation of PMNs in the peritoneal cavities of i.p.-infected mice. Peritoneal accumulation of PMNs rose to peak levels on day 2 in the controls and then declined. The number of PMNs in the peritoneal cavities of the DEStreated mice had risen to significantly higher levels than observed in the controls by day 3 and remained significantly elevated on days 4 and 5. There was a slight, though significant, increase in the number of bacteria in the peritoneal cavities of the DEStreated animals 1 day after i.p. infection (Fig. 4) . On subsequent days the number of bacteria remained lower in the control mice than in the DES-exposed mice and declined to essentially nonexistent quantities in the controls by day 5. The number of bacteria in the DES-treated mice, on the other hand, remained ca. 3 logs higher than in the controls from day 3 through day 5. We did not observe measurable quantities of Listeria cells in the peritoneal cavities of either vehicle-or DES-treated mice after i.v. infection. DISCUSSION These studies demonstrate that pharmacological (i.e., therapeutic) levels of steroidal and nonsteroidal estrogens profoundly alter the susceptibility of mice to L. monocytogenes infection. The ability of estrogenic compounds to alter host resistance to Listeria cells appears to correlate with their estrogenicity. The classical measure of estrogenic activity, uterine growth, is initiated after hormone binding to cytoplasmic receptors and subsequent translocation of the hormone-receptor complex into the nucleus where binding to the nuclear chromatin occurs (10, 20) . DES and 1713-estradiol have similar in vitro uterotrophic potency and binding activity although DES is more potent than estradiol in vivo (19) . DES, 17,3-estradiol, and ct-dienestrol possess in common a phenolic ring structure in the A-ring region of the molecule which is believed to be responsible for specific binding to estrogen receptors (6) . Administration of pharmacological levels of these compounds caused increased mortality after Listeria infection. Increased mortality also occurred in estrogen-treated ovariectomized mice; thus, the effects of estrogenic compounds on Listeria resistance are not indirectly mediated through ovarian dysfunction. Steroidal and nonsteroidal compounds possessing little or no estrogenic activity did not alter Listeria resistance. These compounds included progesterone, 5o±-DHT, ,B-dienestrol, and zearalenol. 3-Dienestrol, although not estrogenic, is a potent genotoxic metabolite of DES capable of binding to macromolecules and potentially a direct carcinogen (37) . 5ox-DHT is a hormonally active metabolite of testosterone which demonstrates slight uterine binding activity but only at relatively high doses (40) . Zearalenol possesses 20% of the receptor-binding activity of estradiol and only 1% of its uterotrophic activity (16) , suggesting that binding alone will not induce altered resistance. Exposure to 2.8 pmol of corticosterone also had no effect on Listeria-related mortality. Cortisone acetate has been reported to affect Listeria resistance, but at dosage levels higher than used in our experiments (34, 39) . In contrast, exposure to as little as 0.04 [imol of DES or estradiol significantly increased mortality.
A direct relationship between estrogenic activity and increased susceptibility to L. monocytogenes was also evidenced in studies with the estrogen antagonist tamoxifen. This compound is a nonsteroidal derivative of triphenylethylene, has only limited estrogenic activity, and putatively acts as an antiestrogen by inhibiting the replenishment of cytoplasmic estrogen receptors (43) . We observed that the effects of estradiol on Listeria resistance are blocked by concurrent administration of tamoxifen. This further supports the idea that estrogen-induced modifications of Listeria resistance are, at least in part, due to estrogenic activity and thus mediated through an operational receptor-like mechanism similar to the cytosolic estrogen receptor involved in uterotrophic responses.
The reported immunological effects associated with the administration of estradiol and DES to rodents include thymic atrophy (5) sion of natural killer cell activity (14, 41) . The mechanisms responsible for the wide range of effects of estrogens on immunological responses are not well understood, although increasing evidence suggests that estrogen-dependent immunotoxicity is, in part, mediated through the thymus. For example, experimental evidence suggests that the binding of estrogen to specific cytosolic receptors in thymic epithelial cells influences the quality and quantity of thymic hormones (9, 24, 42) . That this may represent a negative regulatory function was suggested in studies in which surgical TX was found to protect against estrogen-induced immunosuppression (24) . In the present study, we observed that TX was protective against estrogen-induced increased susceptibility to L. monocytogenes. Thus, certain of the effects of estrogens on host resistance are related to alterations in thymic immunoregulation. We noted, however, that when the exposure level of estradiol was increased, the protective effect of TX was lost. These findings may be reflective of a dual mode of action of estrogens: one which is mediated by the thymus at low-dosage levels and a second which directly affects immune functions at high-dosage levels. This is consistent with the proposed mechanisms responsible for changes in immune function by estrogens (M. I. Luster, R. W. Pfeifer, and A. N. Tucker, in J. Dean, A. E. Munson, M. I. Luster, and H. Amos [ed.], Target Organ Toxicity, in press).
In a similar experiment, transplantable syngeneic tumor cell growth was used as the infectivity model. The resistance of mice to syngeneic tumor cells is primarily dependent on macrophage-and T cell-mediated immunity (45) and has been previously shown by us to be decreased by estrogen exposure (4) . In the present study, we demonstrated that the effects of estrogen on resistance to syngeneic tumor cells could be inhibited by adult TX. This further confirms that the thymus plays a role in estrogen-induced modulation of host resistance.
The ability of mice to resist Listeria infection primarily depends on the cell-mediated immune response. Recovery is thought to require T-cell activation of the bactericidal properties of macrophages (21, 25, 35) and the accumulation of large numbers of macrophages at infective foci (28, 33, 34, 38) . Since estrogen exposure clearly alters macrophage and T-cell functions, experiments were performed to determine the role of these alterations on the ensuing Listeria infection. The effects of estrogens on T cells are multifold. For example, estrogen exposure induces thymic involution (1, 5) and depresses delayed hypersensitivity as well as lymphoproliferative responses to allogeneic leukocytes and T-cell mitogens (13, 23) . Estrogens may also depress interleukin-2 production (11) . Indirect evidence that estrogens disrupt the T cell-mediated immune response to Listeria cells was provided by following the growth of bacteria in the spleens of estrogen-exposed animals. Substances which are directly toxic to macrophages are presumably evidenced by greater than normal numbers of bacteria in the liver and spleen as early as 24 h after infection. T cell-mediated defects, on the other hand, are evidenced by greater than normal numbers of bacteria in these organs only later in the infection, when complete elimination of the bacteria is thought to be dependent on T cell-dependent events such as macrophage activation (48) . As was shown in this study and suggested by preceding studies in this laboratory (4) , the number of bacteria in the spleens of estrogen-treated mice was greater than in control mice only later in the infection. This may indicate that the ability of nonimmune macrophages to ingest and destroy Listeria cells is not affected by estrogen exposure but that the disruptive effects of estrogens on Listeria resistance are related to altered T-cell functions.
The known effects of estrogen exposure on the mononuclear phagocyte system include augmented antigen clearance by the liver (22, 31) and increased peritoneal macrophage activity (1) . Peritoneal macrophages from estrogen-treated mice do not appear to be fully activated but possess certain characteristics of inflammatory macrophages. They are hyperphagocytic, inhibit tumor cell growth in vitro, and secrete increased quantities of plasminogen activator ( (29) . However, estrogen exposure may increase the number of liver macrophages as well as their activity (50) . Thus, augmented early destruction of Listeria cells in the livers of estrogen-exposed mice could be due to increased macrophage numbers rather than, or in addition to, an enhancement of the bactericidal capacity of individual cells.
Later in the infection, when macrophage accumulation and activation are thought be be responsible for elimination of the bacteria (25, 28, 33, 34) , Listeria titers in infective foci of DES-exposed mice were greatly elevated above control levels. The fulminant growth of Listeria cells which occurred in the peritoneal cavities of DES-exposed mice after an i.p. infection was accompanied by a delay in the accumulation of macrophages and lymphocytes at the site of infection. The inability of DES-exposed mice to increase the number of macrophages in infective foci at the same rate as controls may account for the virtually unrestricted growth of the bacteria in these animals. The delay in mononuclear cell (34, 44) , there is now evidence that they can kill Listeria cells in vitro (3) . Consequently, an estrogeninduced defect in the ability of these cells to destroy the bacteria cannot be ruled out. There is no obvious explanation for sustained PMN accumulation at infective foci after DES exposure. Other anti-inflammatory agents, most notably the glucocorticosteroids, may induce similar effects.
Cortisone acetate, for example, augments PMN accumulation in the livers of Listeria-infected mice (34) . Dexamethasone enhances PMN migration in vitro but has the opposite effect on macrophages (46) .
In summary, estrogen-induced suppression of Listeria immunity may be mediated by an operational hormone receptor mechanism and is partially regulated through the thymus. The effects of estrogen on host defenses include a depression in the ability of exposed mice to accumulate monocytes and lymphocytes or eliminate bacteria at infective foci.'These effects may be related to an estrogeninduced suppression of the T cell-dependent immune response. These findings are of relevance in view of the fact that estrogenic compounds such as DES and estradiol are commonly used for both therapeutic and agricultural purposes (27, 32) . Clinical observations have provided evidence that the therapeutic use of estrogens can induce immunotoxicity (Luster et al., in Dean'et al. (ed.) , Target Organ Toxicity, in press), and the apparent ability of these compounds to affect susceptibility to infectious diseases should be considered an additional health hazard.
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